Skip to main content
Equibles

FMR LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 315066 BOSTON, MA
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$241,121,985
+$122,105,231 QoQ
Shares Held
762,827
+28.0% QoQ
Ownership
3.83%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 415 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. LGND ranks #62 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in LGND

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $241,121,985 762,827
2026-03-31 $119,016,754 596,127
2025-12-31 $109,500,835 579,155
2025-09-30 $80,993,898 457,231
2025-06-30 $2,981,029 26,223
2025-03-31 $2,621,455 24,933
2024-12-31 $2,017,741 18,831
2024-09-30 $1,276,047 12,749
2024-06-30 $165,149 1,960
2024-03-31 $132,164 1,808
2023-12-31 $713,700 9,993
2023-09-30 $20,252 338
2023-06-30 $40,303 559
2023-03-31 $41,634 566
2022-12-31 $27,387 410
2022-09-30 $69,576 808
2022-06-30 $69,234 776
2022-03-31 $135,437 1,204
2021-12-31 $64,718 419
2021-06-30 $147,587 1,125
2021-03-31 $169,218 1,110
2020-12-31 $89,902 904
2020-09-30 $106,090 1,113
2020-06-30 $472,230 4,222
2020-03-31 $833,005 11,455